CyDex Pharmaceuticals, Inc.Lenexa, KS, United States (NASDAQ (GM): CYDX Proposed)

Tools:

What Additional CyDex Information Is Available From Hoover's?

Today's Special Offer

CyDex Income Statement

All amounts in millions of except per share amounts.
View: Annual
Dec 07 Dec 06 Dec 05
Revenue 12.7 11.6 8.8
Cost of Goods Sold 2.5 2.5 2.6
Gross Profit 10.2 9.1 6.3
Gross Profit Margin 80.3% 78.6% 70.9%
SG&A Expense 13.4 7.1 6.9
Depreciation & Amortization -- -- --
Operating Income (3.2) 2.0 (0.7)
Operating Margin -- 17.1% --
Nonoperating Income 0.6 0.4 0.2
Nonoperating Expenses 0.0 0.0 0.0
Income Before Taxes (2.6) 2.4 0.4
Income Taxes 0.0 0.1 0.0
Net Income After Taxes (2.6) 2.4 0.4

Continuing Operations (2.6) 2.4 0.4
Discontinued Operations 0.0 0.0 0.0
Total Operations (2.6) 2.4 0.4
Total Net Income (2.6) 2.4 0.4
Net Profit Margin -- 20.3% 5.0%

Diluted EPS from Total Net Income ($) -- -- --
Dividends per Share -- -- --